Literature DB >> 15642266

Structural basis for vertebrate filamin dimerization.

Regina Pudas1, Tiila-Riikka Kiema, P Jonathan G Butler, Murray Stewart, Jari Ylänne.   

Abstract

Filamins are essential in cell motility and many developmental processes. They are large actin cross linking proteins that contain actin binding domains in their N termini and a long rod region constructed from 24 tandem Ig domains. Dimerization is crucial for the actin crosslinking function of filamins and requires the most C-terminal Ig domain. We describe here the crystal structure of this 24th Ig domain (Ig24) of human filamin C and show how it mediates dimerization. The dimer interface is novel and quite different to that seen in the Dictyostelium discoideum filamin analog. The sequence signature of the dimerization interface suggests that the C-terminal domains of all vertebrate filamins share the same dimerization mechanism. Furthermore, we show that point mutations in the dimerization interface disrupt the dimer and that the dissociation constant for recombinant Ig24 is in the micromolar range.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642266     DOI: 10.1016/j.str.2004.10.014

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  51 in total

Review 1.  Filamins in mechanosensing and signaling.

Authors:  Ziba Razinia; Toni Mäkelä; Jari Ylänne; David A Calderwood
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

2.  Filamin A controls matrix metalloproteinase activity and regulates cell invasion in human fibrosarcoma cells.

Authors:  Massimiliano Baldassarre; Ziba Razinia; Nina N Brahme; Roberto Buccione; David A Calderwood
Journal:  J Cell Sci       Date:  2012-05-17       Impact factor: 5.285

3.  Molecular basis of the C-terminal tail-to-tail assembly of the sarcomeric filament protein myomesin.

Authors:  Nikos Pinotsis; Stephan Lange; Jean-Claude Perriard; Dmitri I Svergun; Matthias Wilmanns
Journal:  EMBO J       Date:  2007-12-06       Impact factor: 11.598

4.  Biochemical basis of the interaction between cystic fibrosis transmembrane conductance regulator and immunoglobulin-like repeats of filamin.

Authors:  Laura Smith; Richard C Page; Zhen Xu; Ekta Kohli; Paul Litman; Jay C Nix; Sujay S Ithychanda; Jianmin Liu; Jun Qin; Saurav Misra; Carole M Liedtke
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

5.  Phosphorylation facilitates the integrin binding of filamin under force.

Authors:  Harvey S Chen; Kevin S Kolahi; Mohammad R K Mofrad
Journal:  Biophys J       Date:  2009-12-16       Impact factor: 4.033

6.  Identification and characterization of multiple similar ligand-binding repeats in filamin: implication on filamin-mediated receptor clustering and cross-talk.

Authors:  Sujay Subbayya Ithychanda; Dennis Hsu; Hanhan Li; Linda Yan; David D Liu; Darwen Liu; Mitali Das; Edward F Plow; Jun Qin
Journal:  J Biol Chem       Date:  2009-10-14       Impact factor: 5.157

7.  The structure of the GPIb-filamin A complex.

Authors:  Fumihiko Nakamura; Regina Pudas; Outi Heikkinen; Perttu Permi; Ilkka Kilpeläinen; Adam D Munday; John H Hartwig; Thomas P Stossel; Jari Ylänne
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

8.  Migfilin, a molecular switch in regulation of integrin activation.

Authors:  Sujay Subbayya Ithychanda; Mitali Das; Yan-Qing Ma; Keyang Ding; Xiaoxia Wang; Sudhiranjan Gupta; Chuanyue Wu; Edward F Plow; Jun Qin
Journal:  J Biol Chem       Date:  2008-12-13       Impact factor: 5.157

9.  N-terminal strands of filamin Ig domains act as a conformational switch under biological forces.

Authors:  Barry A Kesner; Feng Ding; Brenda R Temple; Nikolay V Dokholyan
Journal:  Proteins       Date:  2010-01

10.  Structural basis of the migfilin-filamin interaction and competition with integrin beta tails.

Authors:  Yatish Lad; Pengju Jiang; Salla Ruskamo; David S Harburger; Jari Ylänne; Iain D Campbell; David A Calderwood
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.